It’s been an thrilling 12 months for the diagnostics sector given all of the exercise we have now seen since Covid-19 turned a worldwide pandemic. Finalists for the diagnostics observe at INVEST Pitch Good embrace span biosensors, higher respiratory infections, breast most cancers screening, in vitro mobile immunoassays, dysphagia diagnostics, and neuroscience.
The INVEST Pitch Perfect contest is a part of our INVEST conference April 19-23, which will probably be hosted on-line resulting from Covid-19. It contains 5 tracks for startups: biopharma, medical gadgets, diagnostics, well being IT and well being providers.
Click here to see the remainder of the agenda.
Finalists fulfill one of the next standards:
- Raised a minimum of $1 million;
- Raised a Collection A spherical;
- Have a minimum of one certified institutional investor or strategic investor
Judges for the observe embody:
Listed here are the finalists:
EDP Biotech develops and commercializes handy, cost-effective diagnostics which detect illness early.
GRIP Molecular’s single-use biosensor and cellular app gives customers extremely correct and complete medical diagnostic data in minutes, anytime and anyplace. The patented, graphene-enabled solid-state digital platform know-how is straightforward to make use of and doesn’t require chemical reagents or a separate reader. GRIP’s underlying know-how can concurrently detect the presence of infectious illness pathogens and characterize the host response, together with the immune response, to allow information-enabled prognosis and the speedy software of acceptable remedy. The primary product will concurrently present diagnostic data for COVID-19, Influenza A/B and different frequent higher respiratory infections. Proof of idea has been accomplished and growth is underway with preliminary product launch anticipated in 2023.
Inanovate has developed a patented blood evaluation system (the Bio-ID) that improves the fee, accessibility, and accuracy of diagnostic checks. The primary software of the Bio-ID is a brand new blood take a look at for use as a complement to mammography to assist scale back false constructive leads to breast most cancers screening. Roughly 10% of the 39 million screening mammograms carried out yearly within the US require follow-up testing to resolve the prognosis, but greater than 95% of those are ‘false positives’ during which no most cancers is detected. The financial price of false-positive mammograms is ~$4 billion, and >1 million ladies are uncovered to dangers related to subsequent diagnostics. Inanovate seeks to handle this subject by a easy, cheap blood take a look at, that may present extra knowledge on a sufferers most cancers danger to assist inform clinicians whether or not observe up procedures are crucial.
Loop Diagnostics is a novel first-in-class in vitro mobile immunoassay that identifies sepsis after the first-hour of bloodstream an infection. Now we have developed a patented technique and package (with disposable) to establish immune exercise biomarkers, that’s 3x extra delicate than the present biomarker competitor (PCT) and gives a 10x sooner prognosis than pathogen identification. Our biomarker seems after the primary hour of an infection, lengthy earlier than PCT can detect the presence of Sepsis. It will permit healthcare professionals to start correct therapy earlier – lowering the severity of the illness and reducing the variety of antibiotics or different medicine crucial for therapy.
Patheous Health is constructing a Dysphagia Care-as-a-Service (CaasSD) enterprise to enhance entry to feeding and swallow healthcare for senior care suppliers. Our diagnostic and therapeutic options affect sufferers that endure from swallowing impairment and vitamin consumption in a number of care settings, together with expert nursing, dwelling well being, in-patient rehabilitation, assisted dwelling and neighborhood dwelling adults. Patheous Well being closed the Collection A spherical in March 2020 and purchased the biggest US supplier of onsite dysphagia diagnostics. The acquisition offered fast revenues and 375 senior care supplier facility purchasers. We’re constructing on our buyer base, increasing our value-based service, and constructing a deep channel to introduce our Dysphagic Care-as-a-Service platform. Our group consists of world-class specialists in dysphagia analysis and care and supported by skilled executives that know how one can construct a scientific care enterprise.
Virtuleap unlocks neuroscience with digital actuality to assist pharmaceutical firms speed up the approval of medication designed to deal with cognitive sicknesses like Alzheimer’s illness.
Photograph: Adam Taylor, Getty Photographs